MedPath

A multicenter, prospective, randomized, double-blind, placebo-controlled, international study to assess the effects of 2g per day of strontium ranelate versus placebo on the time to fracture healing in osteoporotic men and women. - The fracture healing study

Conditions
Osteoporotic men and post menopausal osteoporotic women with a fracure of the distal radius
MedDRA version: 9.1Level: LLTClassification code 10031288
Registration Number
EUCTR2009-014271-41-IT
Lead Sponsor
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Men or postmenopausal women, aged >=50 years - Osteoporotic patient with a fracture of the distal radius (Colles` fracture).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Multiple trauma with serious lesion and/or fractures in another anatomical region - Known skeletal disease - Displaced fracture - Fracure requiring surgical intervention - Associated fracture of the ulnar shaft - Fracture of the dorsal/volar margin (Barton or reverse Barton fracture) - Volar angulation -(Smith fracture or reverse Colles` fracture) - Vertical fracture and/or fracture of the radial styloid - History or increased risk of venous thrombo-embolism - Known liver insuffuciency ir renal insufficiency.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath